JANSSEN RESEARCH & DEVELOPMENT, LLC

JANSSEN RESEARCH & DEVELOPMENT, LLC specializes in biotechnology research and development, focusing on the discovery and advancement of novel therapeutic platforms and biomedical innovations. Their technical expertise lies in translational research, preclinical development, and early-stage drug pipeline optimization, with a strong emphasis on molecular biology, cell-based assays, and biotherapeutic formulation. The company demonstrates a focused capability in supporting the development of biologics and targeted interventions, leveraging laboratory-scale validation and data-driven candidate selection to accelerate innovation from concept to proof-of-concept. Their approach integrates rigorous experimental design with regulatory-aligned documentation practices, positioning them as a specialized R&D partner for complex biological systems. The contractor has delivered services under the Department of Health and Human Services, primarily supporting research initiatives aligned with public health priorities, including infectious disease, immunology, and precision medicine programs. Their engagement with HHS reflects a pattern of collaboration on mission-critical biomedical projects requiring high scientific rigor and compliance with federal research standards. The primary industry focus is on NAICS 541714—research and development in biotechnology—where the company operates at the intersection of academic discovery and government-funded translational science. This vertical specialization underscores their role in advancing non-nanobiotechnology-based biologics, including protein therapeutics, recombinant enzymes, and cell signaling modulators. JANSSEN RESEARCH & DEVELOPMENT, LLC is structured as a 2L entity based in Raritan, New Jersey, with no public certifications on record. Their geographic footprint is centered in the Northeast biopharma corridor, enabling proximity to academic medical centers and federal research hubs. The company maintains a niche market position as a focused, contract-based R&D provider for government-sponsored biomedical innovation, operating without broad commercial or institutional branding but with clear technical precision in its domain.